Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
By
vgreene
, 15 January, 2015
CM
By
vgreene
, 15 January, 2015
CKD
By
vgreene
, 15 January, 2015
CCB
By
vgreene
, 15 January, 2015
BB
By
vgreene
, 15 January, 2015
III:Either no benefit, or harm
By
vgreene
, 15 January, 2015
IIb:Benefit ≥ Risk; may be considered
By
vgreene
, 15 January, 2015
IIa:Benefit >> Risk; reasonable to perform
By
vgreene
, 15 January, 2015
I:Benefit >>> Risk; should be performed
By
vgreene
, 15 January, 2015
C:Only consensus opinion of experts, case studies, or standard of care
By
vgreene
, 15 January, 2015
B:Data derived from a single RCT or nonrandomized trials
Pagination
First page
Previous page
…
Page
3857
Page
3858
Page
3859
Page
3860
Current page
3861
Page
3862
Page
3863
Page
3864
Page
3865
…
Next page
Last page
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube